InterGard Synergy Post-Marketing Surveillance Study

NCT01698671 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2013-11-26

No results posted yet for this study

Summary

The purpose of the study is to assess the performance and safety of the InterGard Synergy vascular graft.

Conditions

  • Aortic Aneurysm, Abdominal
  • Occlusive Disease of Artery of Lower Extremity

Interventions

DEVICE

InterGard Synergy Vascular Graft

Sponsors & Collaborators

  • Maquet Cardiovascular

    lead INDUSTRY

Principal Investigators

  • Max Zegelman, MD · Krankenhaus Nordwest

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-10-31
Completion
2014-05-31

Countries

  • Austria
  • Germany

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01698671 on ClinicalTrials.gov